Clarivate, Barcelona, Spain.
Drugs Today (Barc). 2022 May;58(5):249-255. doi: 10.1358/dot.2022.58.5.3437189.
The Drug Information Association (DIA) Europe held its 2022 annual meeting as a hybrid event, both as an in-person meeting in Brussels, Belgium, and as a virtual meeting. Many topics were discussed during this 3-day meeting, including the lessons learnt from the first 5 years' experience of the PRIME (PRIority MEdicine) scheme, the benefits and tools of the Clinical Trials Regulation, the roadmap of the electronic product information, the implementation of the substance, product, organization and referentials (SPOR) management services, and how real-world data, real-world evidence and digital health tools are changing the way clinical trials and research are performed.
药物信息协会（DIA）欧洲以混合会议的形式举办了其 2022 年年会，该会议既是在比利时布鲁塞尔举行的现场会议，也是虚拟会议。在为期 3 天的会议中，讨论了许多主题，包括从 PRIME（优先医学）计划的前 5 年经验中吸取的教训、临床试验法规的好处和工具、电子产品信息的路线图、物质、产品、组织和参考资料（SPOR）管理服务的实施，以及真实世界数据、真实世界证据和数字健康工具如何改变临床试验和研究的进行方式。
